Join
Live feed
·
INSIDERFilingvia Quantisnow
Relmada Therapeutics Inc. logo

SEC Form 4: Traversa Sergio bought $115,804 worth of shares (55,250 units at $2.10), increasing direct ownership by 62% to 144,024 units

ByQuantisnow·Wall Street's wire, on your screen.
RLMD· Relmada Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RLMD (Relmada Therapeutics Inc.) and more on Quantisnow.